Floatz logo

Therapeutic Asset Ratings

162 results matching 1 filter

128,359 assets · 8,667 sponsors · 3,127 indications
Methodology v0.2
AssetSponsorPhaseRating
Irinotecan
Advanced Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Letrozole
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Orelabrutinib
Primary Central Nervous System Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
PREDNISONE TABLETS
Lenalidomide
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Recombinant Mutant Human Tumor Necrosis Factor
peritoneal carcinomatosis
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Rimegepant
Vestibular Migraine
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Tafolecimab
Extensive Disease Small Cell Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Tafolecimab
small cell lung carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Thiotepa
glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Toripalimab
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Toripalimab
estrogen-receptor positive breast cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
VENLOR
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
(+)-VINCRISTINE
Advanced Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
(+)-VINCRISTINE
Lenalidomide
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
VITAMIN D
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
cc-5013
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2/3CCC (53)
6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL
ischemic stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (52)
Empagliflozin
Acute Ischemic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (52)
Esmolol
Ischemic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (52)
Terazosin
Ischemic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (52)
Tucidinostat
Liver Metastases
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2/3CCC (52)
Benmelstobart
primary peritoneal carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (51)
tj0113
Parkinson disease
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (51)
Egfr/B7H3 Car-T
glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1/2CCC (50)
Atirizumab
hepatocellular carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (48)
Showing 76 to 100 of 162 assets
PreviousPage 4 of 7Next